FR2598706B1 - TETRAHYDRONAPHTALENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD OF PREPARATION - Google Patents

TETRAHYDRONAPHTALENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD OF PREPARATION

Info

Publication number
FR2598706B1
FR2598706B1 FR878706564A FR8706564A FR2598706B1 FR 2598706 B1 FR2598706 B1 FR 2598706B1 FR 878706564 A FR878706564 A FR 878706564A FR 8706564 A FR8706564 A FR 8706564A FR 2598706 B1 FR2598706 B1 FR 2598706B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
tetrahydronaphtalene
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR878706564A
Other languages
French (fr)
Other versions
FR2598706A1 (en
Inventor
Michael Klaus
Peter Loeliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1938/86A external-priority patent/CH668962A5/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2598706A1 publication Critical patent/FR2598706A1/en
Application granted granted Critical
Publication of FR2598706B1 publication Critical patent/FR2598706B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
FR878706564A 1986-05-13 1987-05-11 TETRAHYDRONAPHTALENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD OF PREPARATION Expired - Fee Related FR2598706B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1938/86A CH668962A5 (en) 1986-05-13 1986-05-13 New hydroxy:phenyl:propenyl substd. naphthalene cpds.
CH74287 1987-02-26

Publications (2)

Publication Number Publication Date
FR2598706A1 FR2598706A1 (en) 1987-11-20
FR2598706B1 true FR2598706B1 (en) 1990-07-06

Family

ID=25685550

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878706564A Expired - Fee Related FR2598706B1 (en) 1986-05-13 1987-05-11 TETRAHYDRONAPHTALENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD OF PREPARATION

Country Status (20)

Country Link
CN (1) CN87103524A (en)
AU (1) AU7277987A (en)
BE (1) BE1001668A5 (en)
DE (1) DE3715809A1 (en)
DK (1) DK232087A (en)
ES (1) ES2005572A6 (en)
FI (1) FI872027A (en)
FR (1) FR2598706B1 (en)
GB (1) GB2190378B (en)
HU (1) HU198002B (en)
IL (1) IL82448A0 (en)
IT (1) IT1203954B (en)
LU (1) LU86866A1 (en)
MC (1) MC1817A1 (en)
NL (1) NL8701101A (en)
NO (1) NO871961L (en)
NZ (1) NZ220215A (en)
PT (1) PT84860B (en)
SE (1) SE8701933L (en)
ZW (1) ZW6587A1 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602130A (en) * 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
US5264578A (en) 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
CA2017956A1 (en) * 1989-07-06 1991-01-06 Werner Bollag Use of retinoids
US5183827A (en) * 1989-09-19 1993-02-02 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5264456A (en) * 1989-12-29 1993-11-23 Allergan, Inc. Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
US5324840A (en) * 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
US5475022A (en) * 1993-10-18 1995-12-12 Allergan, Inc. Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
US5426118A (en) * 1993-12-30 1995-06-20 Allergan, Inc. [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5618943A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5534641A (en) * 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5556996A (en) * 1994-12-29 1996-09-17 Allergan Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5543534A (en) * 1994-12-29 1996-08-06 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US5618931A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US6025388A (en) 1995-04-26 2000-02-15 Allergan Sales, Inc. Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
US5616712A (en) * 1995-05-16 1997-04-01 Allergan Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5675033A (en) * 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5965606A (en) 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US5688957A (en) * 1995-12-29 1997-11-18 Allergan (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5808124A (en) * 1996-06-21 1998-09-15 Allergan O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5747542A (en) * 1996-06-21 1998-05-05 Allergan Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
US5741896A (en) 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) * 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5760276A (en) 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US6380256B1 (en) 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6369225B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
CA1162200A (en) * 1981-02-13 1984-02-14 Michael Klaus Process for the manufacture of indanyl (or tetrahydronaphthyl)propenyl phenyl derivatives
EP0084667B1 (en) * 1982-01-23 1985-09-18 BASF Aktiengesellschaft Phenylethylene derivatives, their preparation and use as medicines
DE3202100A1 (en) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen SUBSTITUTED 4-HYDROXYANILIDES, ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3602473A1 (en) * 1986-01-28 1987-07-30 Basf Ag VINYLPHENOL DERIVATIVES, THEIR PRODUCTION AND USE

Also Published As

Publication number Publication date
DK232087D0 (en) 1987-05-06
NL8701101A (en) 1987-12-01
MC1817A1 (en) 1988-03-18
ZW6587A1 (en) 1987-12-02
PT84860B (en) 1990-02-08
GB2190378B (en) 1990-11-14
GB2190378A (en) 1987-11-18
NO871961D0 (en) 1987-05-12
PT84860A (en) 1987-06-01
FR2598706A1 (en) 1987-11-20
BE1001668A5 (en) 1990-02-06
AU7277987A (en) 1987-11-19
FI872027A0 (en) 1987-05-07
IT8720232A0 (en) 1987-04-23
DE3715809A1 (en) 1987-11-19
HU198002B (en) 1989-07-28
GB8711205D0 (en) 1987-06-17
SE8701933L (en) 1987-11-14
DK232087A (en) 1987-11-14
HUT43806A (en) 1987-12-28
LU86866A1 (en) 1988-06-13
SE8701933D0 (en) 1987-05-11
ES2005572A6 (en) 1989-03-16
NO871961L (en) 1987-11-16
NZ220215A (en) 1990-06-26
IL82448A0 (en) 1987-11-30
CN87103524A (en) 1987-12-02
FI872027A (en) 1987-11-14
IT1203954B (en) 1989-02-23

Similar Documents

Publication Publication Date Title
FR2598706B1 (en) TETRAHYDRONAPHTALENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD OF PREPARATION
FR2466248B1 (en) DERIVATIVES OF NON-STEROID ANTI-INFLAMMATORY AGENTS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT85279A (en) PROCESS FOR THE PREPARATION OF NITROFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2595351B1 (en) INDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT77488B (en) PROCESS FOR PREPARING PHENYL-1-PIPERIDINO-2-PROPANOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
PT78340B (en) PROCESS FOR THE PREPARATION OF NOVEL 3', 4 ', 5,7-FLAVONE TETRAHYDROXY DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2567885B1 (en) 3-AMINOPROPOXYARYL DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT81310A (en) PROCESS FOR PREPARING PIPERIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PT80921A (en) PROCESS FOR THE PREPARATION OF ACYLAMINOMETHYL-3-IMIDAZO <1,2-A> PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PT83355A (en) PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT83896A (en) PROCESS FOR THE PREPARATION OF NEW CONJUGATES OF VINBLAS-TINE AND ITS DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2599034B1 (en) 1- (HYDROXYSTYRYL) -5H-2,3, -BENZODIAZEPINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT84452A (en) PROCESS FOR THE PREPARATION OF N -] (2-HYDROXY-2-PHENYL) (PHENYL) METHYLENE-AMINO-2-ETHYL-ACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT83593A (en) PROCESS FOR THE PREPARATION OF 7-ACYL-BENZOXAZINONES AND THEIR DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PT79365A (en) PROCESS FOR THE PREPARATION OF IMIDAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MC2050A1 (en) BENZOPYRANNOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD OF MANUFACTURE
PT82364B (en) PROCESS FOR THE PREPARATION OF NITROFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT74651B (en) PROCESS FOR THE PREPARATION OF PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PT81992A (en) PROCESS FOR THE PREPARATION OF (DIHYDRO-4,5-1H-IMIDAZOLYL-2) -2 DIHYDRO-2,3 INDOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2531708B1 (en) XANTHINE DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT84933B (en) PROCESS FOR THE PREPARATION OF CYCLODEPSIPEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2582835B1 (en) QUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2563519B1 (en) IMINOTHIAZOLIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT75868A (en) PROCESS FOR PREPARING BENZYLIDENIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2565586B1 (en) NAPHTOXAZINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse